Headlines

  • Padres To Acquire Joe Musgrove In 3-Team Trade
  • Mets GM Sent Unsolicited, Explicit Images To Female Reporter In 2016
  • Nationals To Sign Jon Lester
  • Phillies Sign Archie Bradley
  • Yankees, Corey Kluber Agree To Deal
  • Yankees, Aaron Judge Avoid Arbitration
  • Previous
  • Next
Register
Login
  • Hoops Rumors
  • Pro Football Rumors
  • Pro Hockey Rumors

MLB Trade Rumors

  • Home
  • Teams
    • AL East
      • Baltimore Orioles
      • Boston Red Sox
      • New York Yankees
      • Tampa Bay Rays
      • Toronto Blue Jays
    • AL Central
      • Chicago White Sox
      • Cleveland Indians
      • Detroit Tigers
      • Kansas City Royals
      • Minnesota Twins
    • AL West
      • Houston Astros
      • Los Angeles Angels
      • Oakland Athletics
      • Seattle Mariners
      • Texas Rangers
    • NL East
      • Atlanta Braves
      • Miami Marlins
      • New York Mets
      • Philadelphia Phillies
      • Washington Nationals
    • NL Central
      • Chicago Cubs
      • Cincinnati Reds
      • Milwaukee Brewers
      • Pittsburgh Pirates
      • St. Louis Cardinals
    • NL West
      • Arizona Diamondbacks
      • Colorado Rockies
      • Los Angeles Dodgers
      • San Diego Padres
      • San Francisco Giants
  • About
    • MLB Trade Rumors
    • Tim Dierkes
    • Writing team
    • Advertise
    • Archives
  • Contact
  • Tools
    • 2020-21 Top 50 MLB Free Agents With Predictions
    • 2020-21 MLB Free Agent Tracker
    • 2020-21 MLB Free Agent List
    • Projected Arbitration Salaries For 2021
    • 2021 MLB Arbitration Tracker
    • Transaction Tracker
    • Extension Tracker
    • Agency Database
    • Last 100 Comments
  • NBA/NFL/NHL
    • Hoops Rumors
    • Pro Football Rumors
    • Pro Hockey Rumors
  • App
  • Chats
Go To Pro Hockey Rumors
Go To Hoops Rumors

Chris Sale

Pitching Notes: Soria, Zimmermann, Sale, Price, LeBlanc

By Jeff Todd | January 13, 2021 at 11:10pm CDT

It seems veteran hurler Joakim Soria is drawing quite a lot of interest from the American League West. MLB.com’s Jon Morosi tweets that the Angels, Astros, Athletics, and Rangers are all pursuing Soria to some degree. Of course, most teams could stand to add an experienced late-inning reliever coming off of a quality season, so it stands to reason that just about every club in a competitive division would give a look. Soria, 36, registered a strong 2.82 ERA last year in Oakland, though that’s hardly a determinative measure on its own for a reliever in a shortened season. The well-traveled hurler managed only a 9.6% swinging-strike rate, his lowest in quite some time, and suddenly shifted to being a heavy flyball pitcher (though he wasn’t punished with many home runs in the short sample).

More from the pitching market:

  • After wrapping up a greatly disappointing tenure with the Tigers, Jordan Zimmermann is taking quite a different free agent journey than his first one. It’s fair to wonder whether he’d consider retiring, but the 34-year-old tells MLB.com’s Jason Beck (Twitter link) that he’s instead preparing for another campaign. Zimmermann is sure to draw interest, but not on a guaranteed big-league pact. He has largely been ineffective since coming to Detroit five seasons back and is now also recovering from a forearm injury.
  • The Red Sox could soon get a good sense of the return timeline for star lefty Chris Sale. Per MassLive’s Chris Cotillo (via Twitter), Sale is expected to throw from a mound at some point in the next two weeks or so — if all goes as planned. It’s promising that he’s already nearing that milestone, having undergone his Tommy John procedure at the end of March of 2020. It is hard to imagine that Sale will be ready for the start of the season, but perhaps he could resume competitive pitching relatively early in the 2021 campaign.
  • Also on his way back is Sale’s former teammate David Price. He posted a video on Twitter showing that he’s hard at work preparing for the upcoming season. The Dodgers will surely be interested to see how the ball is coming out of the once-great lefty’s hand after a long respite. Price, who was acquired in a blockbuster nearly one year ago, has yet to take the ball with his new team. He opted out of the 2020 season.
  • Teams looking for a spot starter and long reliever will soon have another option to consider. Southpaw Wade LeBlanc is still plugging away despite suffering a tough elbow injury last year. Per MLB.com’s Jon Morosi (Twitter link), LeBlanc is in good enough form that he’s now preparing for a showcase. LeBlanc posted a resurgent 2018 season but has struggled more recently, so he’s sure to land a non-guaranteed deal when he does sign.
Share 0 Retweet 6 Send via email0

Boston Red Sox Chris Sale David Price Detroit Tigers Houston Astros Joakim Soria Jordan Zimmermann Los Angeles Angels Los Angeles Dodgers Notes Oakland Athletics Texas Rangers Wade LeBlanc

55 comments

Latest On Chris Sale, Eduardo Rodriguez

By Connor Byrne | November 12, 2020 at 7:43pm CDT

Normally contenders, the Red Sox finished with one of the majors’ worst records in 2020, winning just 24 of 60 games. One obvious reason? They received zero contributions from their two best starters, left-handers Chris Sale and Eduardo Rodriguez, who missed the season with health problems.

While it would be nice for the Red Sox to get full years from both Sale and Rodriguez in 2021, that doesn’t appear likely. Regarding Sale, chief baseball officer Chaim Bloom revealed Thursday (via Jason Mastrodonato of the Boston Herald) that the ace won’t be available when next season begins.

“When he comes back, that’s upside,” Bloom said. “Because we know that’s not going to be at the beginning of the season.”

Sale underwent Tommy John surgery in March, and that typically requires a 12- to 15-month recovery period. With that in mind, it’s not surprising that Boston will miss Sale for some portion of time next year. But it’s still less than ideal for a team that signed Sale to a five-year, $145MM extension that just kicked in this past season.

The news is much better for Rodriguez, who on Thursday told MLB Network Radio, “I will be 100 percent ready for next season.” Rodriguez had a career campaign in 2019, but COVID-19 and myocarditis shelved him this year. He was just cleared to begin walking again in late September, so it’s remarkable that Rodriguez is on track to be in the Red Sox’s season-opening rotation in a few months.

Besides Rodriguez and Nathan Eovaldi, the Red Sox might not be sure who will be in their starting staff when next year commences. Their rotation stumbled to a bottom-of-the-barrel 5.34 ERA/5.50 FIP in 2020, though Tanner Houck and Nick Pivetta showed quite a bit of promise over a combined five starts and could earn spots. Otherwise, Boston may try to pick up at least one veteran in free agency to fill out the group.

[RELATED: Red Sox Offseason Outlook]

Share 0 Retweet 3 Send via email0

Boston Red Sox Chris Sale Eduardo Rodriguez

55 comments

Latest On Chris Sale, Eduardo Rodriguez

By Connor Byrne | September 25, 2020 at 4:11pm CDT

SEPT. 25: The Red Sox received “really good news” regarding Rodriguez on Friday, Roenicke told Ian Browne of MLB.com and other reporters. Rodriguez has been cleared to start walking again in a couple of weeks, and the Red Sox are hopeful he’ll be able to have a normal offseason.

SEPT. 24: The Red Sox have gone all season without their two best starters, left-handers Chris Sale and Eduardo Rodriguez, because of health problems. Thanks in part to their absences, the Red Sox have gone a horrible 22-34 – the second-worst record in the American League. However, the hope is that the Red Sox will have one or both of the Sale-Rodriguez tandem back when the 2021 campaign commences.

Manager Ron Roenicke issued updates on Sale and Rodriguez on Thursday, saying (via Jen McCaffrey of The Athletic; Twitter links) that the former is coming along well in his recently started throwing program and the latter will meet with doctors in the coming days to determine next steps. Sale has been on the shelf since undergoing Tommy John surgery in March, while Rodriguez has been down with myocarditis after a bout with the coronavirus.

For Boston’s starting staff, there’s no doubting the importance of Sale or Rodriguez. Sale, a longtime ace, signed a five-year, $145MM extension before the 2019 season, and while his numbers dipped after that, he remained an above-average starter. He still has four guaranteed seasons left on that deal. Rodriguez has given the Red Sox solid production since he debuted in 2015, and with next season being his final year of arbitration eligibility, it could be a crucial campaign for him.

Without Sale and Rodriguez, the Red Sox’s rotation has struggled to the majors’ second-worst ERA and FIP in 2020. They’ve completely lacked solutions beyond Nathan Eovaldi and Martin Perez, who could return to the team next year as complements to Sale and Rodriguez if the latter two are well enough to pitch by then.

Share 0 Retweet 2 Send via email0

Boston Red Sox Chris Sale Eduardo Rodriguez

67 comments

Red Sox Place Chris Sale On 60-Day Injured List

By Mark Polishuk | June 28, 2020 at 8:08pm CDT

The Red Sox placed left-hander Chris Sale on the 60-day injured list, as per a team press release.  Sale underwent Tommy John surgery in March and will miss the entire 2020 season.

Sale’s IL placement was inevitable given the nature of his injury, though as Pete Abraham of the Boston Globe puts it, the “odd timing suggests [the Sox] may have a need for the 40-man spot” that now becomes available with Sale on the injured list.  Boston’s 40-man was full prior to the Sale transaction, so the club now has some flexibility with an open spot.

Jonathan Lucroy could be a possibility for that spot, as MLB.com’s Ian Browne reported earlier today that the Red Sox were working on a restructured version of the veteran catcher’s minor league deal, which is why Lucroy wasn’t on Boston’s initial 60-man player pool for training camp.  With teams expected to carry three catchers on their expanded MLB rosters, the Sox could choose to keep Lucroy and Kevin Plawecki as Christian Vazquez’s backups, which would require a purchase of Lucroy’s minors deal.

Marco Hernandez, Yairo Munoz, and Brian Johnson are some of the other notable non-roster players in the player pool, so Boston could be considering selecting one of their contracts as well.  Or, the Red Sox could be keeping a 40-man spot available should another player come available over the next few weeks.

Share 0 Retweet 6 Send via email0

Boston Red Sox Chris Sale Transactions

11 comments

Red Sox Notes: Sale, Pillar, Witte

By Steve Adams | April 9, 2020 at 9:42pm CDT

Red Sox lefty Chris Sale spoke with reporters this week, acknowledging and even agreeing with some of the frustration felt by fans who suggested he could’ve had the surgery months ago (link via MassLive.com’s Chris Cotillo). However, like most players, Sale viewed surgery as an absolute last resort. “Some people call it wasting time. And hey, it is,” Sale conceded. “We wasted time because the end result is Tommy John. We could have done this six months ago. Having said that, I appreciate the process and I wouldn’t have been 100% go as I was this past time. We turned over every stone. We did every possible thing we could have to prevent this. And I’m okay with that.”

With Sale shelved, the Red Sox’ rotation is going to be a patchwork unit at best, should the season eventually be played out. He’s in the first season of a five-year, $145MM contract he inked with the Red Sox last spring — a deal for which he opted in lieu of testing free agency this past offseason. The 31-year-old southpaw will miss at least the first season of that deal and some of the second, but he’s hopeful that the surgery could allow him to “get 10 more great years” out of his elbow.

More on the Sox…

  • Outfielder Kevin Pillar chatted with Julian McWilliams of the Boston Globe about his revamped approach at the plate heading into the 2020 season. Long a pull-happy hitter, Pillar’s pull tendencies spiked to new heights in 2019, prompting him to refocus on taking the ball up the middle and hitting to all fields. The 31-year-old belted a career-high 21 homers last year — likely in part due to said spike in pull percentage and also due to the juiced ball — but he’s hopeful that more of all-fields approach will bring about a more well-rounded offensive game. Specifically, Pillar noted that going through the offseason and better “understanding how teams value players now” fueled his approach. Pillar, of course, was non-tendered by the Giants after racking up 21 homers, 37 doubles and four triples due in some part to his dismal .287 OBP. He eventually signed a one-year, $4.25MM deal with Boston late in the offseason.
  • Infielder Jantzen Witte, in camp as a non-roster invitee with the Sox, is in many ways a microcosm of the challenges that minor league players face as a whole, writes WEEI’s Rob Bradford. A career-long minor leaguer, Witte had never earned more than $12,000 in a single season. However, he reached minor league free agency this winter and was slated to see his earnings increase considerably, even if he simply spent the year in Triple-A. Witte, though, impressed in camp and caught the eye of manager Ron Roenicke, creating the outside possibility of securing a bench spot with the club and at least putting him on the radar for a midseason call-up. Now, he’s collecting a $400 weekly stipend through the end of May — a rate that checks in under his previous $12,000 salary even when prorated for a whole season — with no clue what’ll happen thereafter (financially speaking). Bradford spoke with Witte about his efforts to remain in shape, the financial uncertainty he’s facing and the woodcarving side business he’s started up while awaiting clarity. The 30-year-old Witte hit .277/.339/.394 in Triple-A last year while playing third base, second base, first base and left field.
Share 0 Retweet 10 Send via email0

Boston Red Sox Chris Sale Kevin Pillar Notes

47 comments

Chris Sale Undergoes Tommy John Surgery

By Jeff Todd | March 30, 2020 at 4:23pm CDT

4:42pm: The surgery was performed today in Los Angeles by Dr. Neal ElAttrache, the Red Sox announced.

4:23pm: We’ve known for some time that Red Sox lefty Chris Sale was destined for Tommy John surgery. But the timing of the procedure was in some doubt given the urgent need for medical resources to deal with the still-growing coronavirus crisis.

Sale has indeed received a replacement ulnar collateral ligament in his left elbow, according to Alex Speier of the Boston Globe (via Twitter). Details on the procedure — timing, location, whether other work was also done — remain unavailable.

Several other pitchers have had TJ surgeries in recent weeks. But even if it’s legal (that depends upon location) and there’s a willing medical provider, it remains a legitimate question whether it’s ethical to perform such elective work given the dire need for medical resources around the world. Emma Baccilieri of SI.com just published a careful examination of the topic.

Now that we know Sale has had his elbow work done, it’s possible to set an estimated timeline for his return. There’s no question he’ll miss all of a truncated 2020 season, no matter how late it goes. But his status for 2021 will depend upon the course of his rehab. If all goes well, he’ll be moving toward competitive moundwork this time next year.

Share 0 Retweet 8 Send via email0

Boston Red Sox Chris Sale

94 comments

Revisiting The Chris Sale Extension

By Mark Polishuk | March 22, 2020 at 9:52pm CDT

The Red Sox were as busy as any team during last spring’s extension flurry, inking a pair of star players to long-term deals that kept them out of the 2019-2020 free agent market.  One of the extensions was a six-year deal with Xander Bogaerts worth $120MM in guaranteed money, a contract that now looks like a pretty sound investment given how Bogaerts followed up a strong 2018 season with an even better 2019 campaign.

The other extension is already off to a rough start.  Chris Sale signed a five-year, $145MM pact covering the 2020-24 seasons, with a club/vesting option for the 2025 campaign worth at least $20MM.  After vastly outperforming his early-career extension with the White Sox (which ended up as a seven-year, $59MM deal once both option years were exercised), Sale now had a new deal that better reflected his status as one of the better pitchers over the last decade.

Exactly one year after that extension was signed, however, the deal looms as a significant misfire for the Red Sox on a couple of different levels.  The club announced on Thursday that Sale would be undergoing Tommy John surgery, which will keep him out of action for whatever becomes of the 2020 season and, in all likelihood, around half of the 2021 season.  The surgery comes on the heels of Sale being shut down last August due to elbow inflamation, and while a platelet-rich plasma injection and some months of rest looked to have the left-hander back on track earlier this winter, Sale was shut down again earlier this month after suffering a flexor strain.

In the short term, this means Boston loses its best pitcher for 2020.  It is a major blow to a rotation that was only okay in 2019, and already had lost David Price after the Sox traded the veteran southpaw and Mookie Betts to the Dodgers in February.  While Sale could conceivably get back to something close to his old form post-surgery and still pitch well over the rest of his contract, the Betts/Price trade plays a critical role in evaluating the big-picture impact of Sale’s extension.

As much as Red Sox ownership has tried to deny it, the luxury tax was clearly a major reason the team was willing to part ways with Betts and Price.  Between moving Betts’ $27.7MM salary and half of the $96MM remaining on Price’s deal, the Sox have gotten themselves under the $208MM Competitive Balance Tax threshold, with Roster Resource projecting a current tax number just shy of $196MM for the 2020 Red Sox.

After two seasons of tax overages, getting under the CBT limit in 2020 would save the Red Sox millions in future tax payments, and theoretically allow them to spend past the threshold again as early as 2021 with only a minimal “first-timer” penalty attached.  As many Boston fans angrily noted over the winter, of course, trading Betts was a pretty extreme measure to achieve these luxury tax savings, and it’s a measure that could have well been avoided had the Red Sox not spent so much money elsewhere….for instance, on Sale’s extension.

Due to deferred money and the structure of the extension, Sale’s contract has a luxury tax number of $25.6MM per season from 2020-24.  Boston’s overall luxury tax payroll stood at roughly $236.3MM at the start of November, so subtracting Sale’s salary would have dropped their figure to $210.7MM, already within shouting distance of the $208MM threshold.  From that point it would’ve been much easier for chief baseball officer Chaim Bloom to make few more cuts and duck under the $208MM line without having to move Betts or Price.

Sale isn’t the only problematic salary on Boston’s payroll, of course, as the four-year, $68MM free agent deal Nathan Eovaldi signed last offseason is also looking questionable after Eovaldi’s injury-plagued 2019.  That said, the Red Sox were far from the only team who thought Eovaldi turned a corner in his breakout 2018 campaign, and they had to outbid the market to re-sign him.

In Sale’s case, the Sox didn’t necessarily have to pursue that extension, particularly given that a few red flags were already apparent.  Sale lost some effectiveness down the stretch in the 2017 season, and had an even shakier ending to his 2018, as shoulder problems limited him to just 17 regular-season innings after July 27 of that year.  The Red Sox were as judicious as possible in spacing out Sale’s appearances during the postseason, when he posted a 4.11 ERA over 15 1/3 innings en route to Boston’s World Series championship.

While Sale had been a very durable pitcher for the bulk of his career, seemingly running out of steam in consecutive seasons should probably have been enough to give the Red Sox some pause before guaranteeing him $145MM through his age 31-35 seasons.  As The Boston Globe’s Peter Abraham recently noted, the Sox may have been motivated to keep Sale out of a lingering regret over the Jon Lester situation from 2014, when the team was perhaps too rigid in extension talks prior to Lester’s final season under contract, which led to Lester being dealt to the Athletics at midseason and then going on deliver several more fine years after signing with the Cubs.

Abraham argues that waiting until after Sale’s final season could have been the more prudent decision for the Sox, as they would have had the added information of Sale’s 2019 numbers.  While the elbow injury was the biggest concern, Sale’s 36% hard-hit ball rate was the highest of his career, and his average fastball velocity dropped by 1.5 mph (to 93.2) from his 2018 speed.  Sale’s 2019 season was the worst of his ten-year MLB career, though given his high standards, a “bad” Chris Sale season was still very solid — a 4.40 ERA, 5.89 K/BB rate, 13.3 K/9 over 147 1/3 innings, and a wealth of advanced metrics (3.39 FIP, 2.93 xFIP, 3.00 SIERA) hinting that Sale’s 4.40 ERA was the result of some bad luck, such as a 1.47 HR/9 that far surpassed his previous career high.

Would this platform year have been enough to make Sale a big player in free agency?  We saw multiple top arms score larger-than-expected contracts this winter, though none of Gerrit Cole, Stephen Strasburg, Madison Bumgarner and company had a mid-August shutdown hanging over their heads.  It’s probably safe to assume that Sale would have still landed a pretty sizable multi-year contract if he had been a free agent, though that also assumes he would have tested the market at all.  His elbow injury could have led to Sale accepting a one-year, $17.8MM qualifying offer to remain in Boston, in the hopes that he’d return to better health in 2020 and deliver a prime season that would lead to a bigger deal in the 2020-21 offseason.

Adding another wrinkle to the mix, perhaps the Red Sox don’t even issue Sale a QO in this scenario out of a concern that he might accept it.  Boston’s approach to payroll seemed to shift radically from the start of the 2019 season to the end, as president of baseball operations Dave Dombrowski was fired and eventually replaced with Bloom, who was under that rather clumsily-issued edict to trim salaries.  In the wake of Sale’s 2019 season, perhaps the Red Sox would’ve been comfortable just letting Sale walk entirely, thus removing one more contractual concern from their books.

A major-market team like the Sox can weather a big contract not working out, but the franchise’s self-imposed desire to avoid the luxury tax suddenly puts many of the big deals of the Dombrowski era (the Sale extension, plus the signings of Price, Eovaldi, and maybe even J.D. Martinez considering the sheer dollars involved) under the radar.  This being said, blaming Dombrowski for Boston’s financial situation is unfair, as these nine-figure deals aren’t happening without the green light from ownership.

Sale’s extension is a prime example of how no transaction exists in a vacuum, as every signing/extension/trade/release/etc. is itself a response to some other move, and also sets off a chain reaction of other moves.  As Abraham pointed out, who knows if Red Sox ownership makes such a move if they had acted differently with Lester all those years ago, or if maybe Sale (or Price, or Eovaldi, or even Dombrowski) ends up in Boston whatsoever if the Sox had still had Lester in their rotation.  Unfortunately for Sale and the Red Sox, the second-guessing over the extension will continue at least until the southpaw can finally get back on the mound.

Share 0 Retweet 14 Send via email0

Boston Red Sox Chris Sale MLBTR Originals Transaction Retrospection

95 comments

Video: Is There Any Hope For Chris Sale?

By Tim Dierkes | March 21, 2020 at 1:33am CDT

With the news of Red Sox pitcher Chris Sale needing Tommy John surgery, MLBTR’s Jeff Todd seeks out comparable aces who were able to return to prominence after the procedure.  Click here for today’s video.

Share 0 Retweet 6 Send via email0

Boston Red Sox Chris Sale MLBTR On YouTube

85 comments

East Notes: Sale, Mets, Nats, Jays

By Connor Byrne | March 20, 2020 at 11:50pm CDT

Boston’s rotation took a hit it may not recover from in 2020 with this week’s news that ace Chris Sale will undergo Tommy John surgery. Chief baseball officer Chaim Bloom, who has been faced with no shortage of adversity during his first several months atop the Red Sox’s baseball department, addressed the surgery decision this week, as Jason Mastrodonato of the Boston Herald details. The left-handed Sale dealt with elbow problems last season, but Bloom and the Red Sox don’t regret putting off his procedure. “Based on everything that went on last summer, the symptoms, the imaging, it seemed very reasonable to me to take that time off and try to rest, strengthen everything and hope for a successful path forward,” Bloom said. “Obviously up until (he felt pain) in early March, there was every indication that he was doing great.” Indeed, it was just this Wednesday that Sale seemed to be progressing in his recovery from a flexor strain. That changed a day later, and now Boston will have to go without its best pitcher until sometime in 2021.

  • The Mets have optioned shortstop Andres Gimenez, right-hander Tyler Bashlor and catcher Ali Sanchez to Triple-A Syracuse, Mike Puma of the New York Post tweets. Bashlor’s the lone member of the trio with major league experience, but he endured immense struggles as a Met last year. The most promising player in the group is the 21-year-old Gimenez, whom MLB.com ranks as the sport’s 84th-best prospect. Gimenez could be a long-term factor in the Mets’ infield, though he hasn’t advanced past Double-A ball yet. He batted .250/.309/.387 with nine home runs and 28 stolen bases over 479 plate appearances at that level last season.
  • The Nationals released reliever Hunter Strickland last weekend, and it turns out that the move was somewhat costly for the club. Had the Nats cut ties with Strickland a week earlier, they would have only had to pay him one-sixth of his $1.6MM salary, Mark Zuckerman of MASNsports.com notes. By parting with Strickland when it did, though, Washington had to fork over a fourth of his money; as a result, it lost $133K or so, per Zuckerman.
  • The coronavirus led the Criminal Court Complex in Clearwater, Fla., to push back Blue Jays catcher Reese McGuire’s court date to April 20, Shi Davidi of Sportsnet relays. McGuire had been scheduled to appear in court Monday as a result of his Feb. 7 arrest on a charge of “exposure of sexual organs,” a first-degree misdemeanor. He could face one year in jail and fines up to $1K.
Share 0 Retweet 7 Send via email0

Andres Gimenez Boston Red Sox Chris Sale Hunter Strickland New York Mets Notes Reese McGuire Toronto Blue Jays Tyler Bashlor Washington Nationals

Comments Closed

Chris Sale To Undergo Tommy John Surgery

By Mark Polishuk | March 19, 2020 at 4:04pm CDT

Red Sox left-hander Chris Sale will undergo Tommy John surgery, as per a team announcement.  Sale will be out of action for roughly the next 12-15 months, as per the usual recovery timeline, and will miss all of the 2020 season.

The news less than three weeks after Sale was diagnosed with a flexor strain, following some elbow soreness in his throwing elbow.  Sale only resumed throwing yesterday, though it’s fair to assume that he experienced further discomfort that resulted in today’s decision.

The Red Sox press release didn’t include any actual date for Sale’s surgery, and Joel Sherman of the New York Post speculated that it could perhaps be some time before Sale actually goes under the knife, given how elective medical procedures are increasingly being canceled (both in the United States and all around the world) in order to give hospitals and doctors more time to focus on the coronavirus pandemic.  It’s also worth wondering if the uncertainty surrounding how much (or any) of the 2020 season will be played could have contributed to Sale’s decision, as he perhaps figured that missing time now was preferable to missing time when games were firmly on the schedule.  Regardless, Sale will now miss whatever exists of the 2020 campaign and also likely at least two or three months of the 2021 season.

Due to his relatively thin stature and his unique throwing motion, durability questions dogged Sale as far back as his days as a vaunted prospect coming out of Florida Gulf Coast University, to the point that he dropped to the White Sox with the 13th pick of the 2010 draft.  Sale proved those criticisms wrong after almost a full decade as one of the game’s best starters, with a career 3.03 ERA, 11.1 K/9, and the best career K/BB rate (5.37) in baseball history, while also averaging 205 innings per season between 2012-17.

The Red Sox acquired Sale in a December 2016 blockbuster trade that saw budding superstar Yoan Moncada go to Chicago, though the hefty price tag was worth it from Boston’s perspective, given Sale’s strong results for the club and his role in helping the Red Sox win the 2018 World Series.  That said, Sale seemed to wear down at the end of the 2017 season and was bothered by shoulder problems late in the 2018 campaign, which led the Sox to limit his innings down the stretch and during their postseason run.

Those injury concerns didn’t stop Boston from signing Sale to a five-year, $145MM extension almost exactly one year ago.  That deal covered the 2020-24 seasons, meaning the Red Sox won’t see any return on that investment for at least the next 15 months.  Warning signs already began to crop up last season, as Sale got off to a slow start and only somewhat looked like himself (a career-high 4.40 ERA, though advanced metrics painted a much more favorable picture of his 2019 performance) over 147 1/3 innings before being shut down in mid-August due to elbow inflammation.  Treatment for that inflammation included a platelet-rich plasma injection in Sale’s elbow, and he was seemingly making good progress in his offseason workouts before a bout of pneumonia set him back a couple of weeks.

Given that so much of Boston’s offseason revolved around getting under the luxury tax threshold, the Sale extension now looms as a seriously questionable decision.  If Sale hadn’t been extended and his $25.6MM average annual value wasn’t on the team’s books, the Red Sox wouldn’t have faced nearly the (self-imposed) crunch to reset their tax bill after two years of overages.  This could have meant the Sox may have explored other, lower-level methods of getting under the $208MM threshold rather than the extreme measure of trading Mookie Betts and David Price to the Dodgers.

With Sale now out of the picture entirely for 2020, Eduardo Rodriguez is now the ace of the Red Sox rotation following the lefty’s big 2019 performance.  E-Rod leaves a staff that is severely lacking in sure things, as Nathan Eovaldi, Martin Perez, and Collin McHugh are all looking to rebound from either injury or inconsistency last season (McHugh could even still wind up in the bullpen).  A long list of names were competing for the final two rotation jobs before Spring Training was halted, and manager Ron Roenicke hinted that the Sox would use an opener/bulk pitcher strategy for at least one of the two slots.

Share 0 Retweet 16 Send via email0

Boston Red Sox Chris Sale Newsstand

194 comments
Load More Posts
Show all

ad: 300x250_1_MLB

    Top Stories

    Padres To Acquire Joe Musgrove In 3-Team Trade

    Mets GM Sent Unsolicited, Explicit Images To Female Reporter In 2016

    Nationals To Sign Jon Lester

    Phillies Sign Archie Bradley

    Yankees, Corey Kluber Agree To Deal

    Yankees, Aaron Judge Avoid Arbitration

    Dodgers, Cody Bellinger Avoid Arbitration

    White Sox Sign Liam Hendriks

    Yankees, DJ LeMahieu Nearing Agreement

    Mets, Brad Hand Discussing Deal

    Recent

    Padres To Acquire Joe Musgrove In 3-Team Trade

    Mets GM Sent Unsolicited, Explicit Images To Female Reporter In 2016

    Nationals To Sign Jon Lester

    Blue Jays To Sign Tyler Chatwood

    Reds Rumors: Torres, Gregorius, Castillo

    Dodgers Have Considered Marcus Semien At Third Base

    Phillies Looking At Further Bullpen Additions

    Red Sox Trade C.J. Chatham To Phillies

    Latest On Masahiro Tanaka

    Phillies Designate Kyle Garlick For Assignment

    Latest Rumors & News

    Latest Rumors & News

    • Trevor Bauer Rumors
    • Francisco Lindor Rumors
    • Kris Bryant Rumors
    • J.T. Realmuto Rumors
    • George Springer Rumors
    • DJ LeMahieu Rumors
    • Marcell Ozuna Rumors
    Trade Rumors App for iOS and Android

    MLBTR Features

    MLBTR Features

    • Go Ad-Free
    • How To Set Up Notifications For Breaking News
    • 2020-21 Top 50 MLB Free Agents With Predictions
    • 2020-21 MLB Free Agent Tracker
    • 2020-21 MLB Free Agent List
    • Projected Arbitration Salaries For 2021
    • 2021 MLB Arbitration Tracker
    • Transaction Tracker
    • Extension Tracker
    • Agency Database
    • MLBTR On Twitter
    • MLBTR On Facebook
    • Team Facebook Pages
    • Hoops Rumors
    • Pro Football Rumors
    • Pro Hockey Rumors

    Rumors By Team

    • Angels Rumors
    • Astros Rumors
    • Athletics Rumors
    • Blue Jays Rumors
    • Braves Rumors
    • Brewers Rumors
    • Cardinals Rumors
    • Cubs Rumors
    • Diamondbacks Rumors
    • Dodgers Rumors
    • Giants Rumors
    • Indians Rumors
    • Mariners Rumors
    • Marlins Rumors
    • Mets Rumors
    • Nationals Rumors
    • Orioles Rumors
    • Padres Rumors
    • Phillies Rumors
    • Pirates Rumors
    • Rangers Rumors
    • Rays Rumors
    • Red Sox Rumors
    • Reds Rumors
    • Rockies Rumors
    • Royals Rumors
    • Tigers Rumors
    • Twins Rumors
    • White Sox Rumors
    • Yankees Rumors

    ad: 160x600_MLB

    Navigation

    • Sitemap
    • Archives
    • Feeds by Team

    MLBTR INFO

    • Advertise
    • About
    • Commenting Policy
    • Privacy Policy

    Connect

    • Contact Us
    • Twitter
    • Facebook
    • RSS Feed

    MLB Trade Rumors is not affiliated with Major League Baseball, MLB or MLB.com

    hide arrowsFOX Sports Engage Network scroll to top
    Close

    Desktop Version | Switch To Mobile Version